Aptissen SA
Sylvie Jamond possesses extensive experience in export management and business development across various sectors. Currently, Sylvie leads as Head of Export and Business Development Manager at Aptissen SA since May 2019, and served as CEO of Aptissen Italia from January 2021 to January 2024. Previous roles include Export Director at PRS Healthcare, specializing in medical equipment repair from September 2014 to 2019, Export Manager at CL Medical, focusing on surgical implants from April 2012 to August 2014, and Export Manager at NOREV SAS, a model car manufacturer, from August 2005 to April 2012. Earlier career experience includes serving as Export Manager at Carré Blanc, a leader in household linen from August 2004 to August 2005. Sylvie's educational background includes degrees in International Management, International Business, Foreign Applied Languages, and Herbalism.
Aptissen SA
Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors' network among more than 90 countries including Europe, South America, Canada, Middle East and Asia. Aptissen's team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid to provide fast pain relief.